Last updated on September 2017

Phase II/III Randomized study of Sorafenib plus Doxorubicin versus sorafenib in patients with advanced HCC

Other Details:

For more information, please contact:
646.776.7532 (local)

For Study Locations, Click Here

Find a site near you

Start Over

Research Center

Located in: Additional Locations, WA USA
  Connect »

Research Center

Located In: Additional Locations, MD USA
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.